Evoke Wealth’s Exact Sciences EXAS Stock Holding History

Evoke Wealth’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,663	Closed	-$270K	–	730
2025 Q4	$270K	Buy	+2,663	New	+$214K	0.01%	546
2020 Q3	–	Sell	-968	Closed	-$84K	–	1050
2020 Q2	$84K	Hold	968	–	–	0.01%	295
2020 Q1	$56.1K	Buy	+968	New	+$78.6K	0.01%	334

Other funds holding EXAS

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PRS

Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return

PWMAG

Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Evoke Wealth's EXAS Position: Q1 2026 in Review

Evoke Wealth sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 2,663 shares — an estimated $270K sold.

Evoke Wealth first reported a position in EXAS in Q1 2020 and held it in 3 quarters. The position peaked at $270K in Q4 2025. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

Evoke Wealth reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
Evoke Wealth sold 2,663 Exact Sciences shares in Q1 2026, an estimated $270K.
Evoke Wealth first reported a position in Exact Sciences in Q1 2020 and held it in 3 quarters.
Evoke Wealth's Exact Sciences position peaked at $270K in Q4 2025.
6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Evoke Wealth's 13F filing for Q1 2026, filed 15 May 2026.